130 results on '"Skorska, Anna"'
Search Results
2. BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice
3. Monitoring the maturation of the sarcomere network: a super-resolution microscopy-based approach
4. Applying 3D-FRAP microscopy to analyse gap junction-dependent shuttling of small antisense RNAs between cardiomyocytes
5. The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
6. Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
7. The CD4+AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function
8. The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
9. Improved transfection in human mesenchymal stem cells: effective intracellular release of pDNA by magnetic polyplexes
10. Continuous Electrical Stimulation Affects Initial Growth and Proliferation of Adipose-Derived Stem Cells
11. Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart
12. Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
13. Quantitative Evaluation of the Sarcomere Network of Human hiPSC-Derived Cardiomyocytes Using Single-Molecule Localization Microscopy
14. GLP: A requirement in cell therapies - perspectives for the cardiovascular field
15. Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans- Plantation Post MI
16. CD271+ Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
17. Additional file 4: Figure S2. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
18. Additional file 7: Figure S6. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
19. Additional file 10: Figure S3. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
20. Additional file 5: Table S3. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
21. Additional file 3: Table S2. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
22. Additional file 6: Figure S5. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
23. Additional file 2: Table S1. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
24. Additional file 9: Figure S7. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
25. Additional file 8: Table S4. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
26. Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans-Plantation Post MI.
27. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
28. Vimentin-Induced Cardiac Mesenchymal Stem Cells Proliferate in the Acute Ischemic Myocardium
29. IS WORK LIFE BALANCE IMPORTANT FOR GENERATION Y?
30. SPATIAL DIVERSITY IN DEVELOPMENT OF KNOWLEDGE INTENSIVE BUSINESS SERVICES IN THE EUROPEAN UNION.
31. Identification and characterization of CD4+AT2R+ T cell subpopulation in humans and rats
32. Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
33. Cardiac Function Improvement and Bone Marrow Response –
34. GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
35. Cardiac Mesenchymal Stem Cells Proliferate Early in the Ischemic Heart
36. The CD4+ AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function
37. Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells following Finnish Sauna: A Pilot Study
38. Exploiting AT2R to Improve CD117 Stem Cell Function In Vitro and In Vivo - Perspectives for Cardiac Stem Cell Therapy
39. Direct sprayed endothelialization, basement membrane and cell junction development on biological and artificial products are highly substrate-dependent and require optimized biofunctionalization
40. Defining Optimized Properties of Modified mRNA to Enhance Virus- and DNA- Independent Protein Expression in Adult Stem Cells and Fibroblasts
41. Selective Migration of Subpopulations of Bone Marrow Cells along an SDF-1α and ATP Gradient
42. GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration.
43. Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105+hMSCs
44. Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
45. Identification of Noncytotoxic and IL-10–Producing CD8+AT2R+ T Cell Population in Response to Ischemic Heart Injury
46. Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells following Finnish Sauna: A Pilot Study.
47. The CD4+ AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function.
48. Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105+ hMSCs.
49. The CD4+AT2R+T cell subpopulation improves post-infarction remodelling and restores cardiac function
50. Angiogenic Potential of Bone Marrow Derived CD133 + and CD271 + Intramyocardial Stem Cell Trans- Plantation Post MI.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.